NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/14/2025
Back to search
Official data from USPTO
EUREKA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EUREKA THERAPEUTICS
ST13
US500000086973388Class
42
Filing
86973388
Registration
5816334
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
11/15/2025
Trademark type
Word
Nice classes
42
Filing date
04/12/2016
Registration date
07/30/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/14/2025
Last transaction
11/15/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
02/14/2006
First use in commerce
02/14/2006
Drawing code
4
Owner type
03
Owner location
EMERYVILLE, CA
Examiner
KEAM,ALEX S
Current location
Historical data usage
Holders and representatives
Holders
EUREKA THERAPEUTICS, INC.
EUREKA THERAPEUTICS, INC.
Representatives
Otto O. Lee INTELLECTUAL PROPERTY LAW GROUP LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical research in the field of immunotherapy; Medical research in the field of antibody-based therapies; Medical research services in the field of immunotherapy; Contract research services in the field of immunotherapymedical research in the field of immunotherapy for others
Publications
History of USPTO decisions and trademark events.
37 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/14/2025
E815
TEAS SECTION 8 & 15 RECEIVED
07/29/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2019
PUBO
PUBLISHED FOR OPPOSITION
05/14/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2019
EXPT
EXPARTE APPEAL TERMINATED
04/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/20/2019
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
03/11/2019
EXPI
EX PARTE APPEAL-INSTITUTED
12/13/2018
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
12/13/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/13/2018
GNFR
FINAL REFUSAL E-MAILED
06/13/2018
CNFR
FINAL REFUSAL WRITTEN
06/13/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/30/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/27/2017
GNRT
NON-FINAL ACTION E-MAILED
11/27/2017
CNRT
NON-FINAL ACTION WRITTEN
11/27/2017
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/18/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/16/2016
GNSL
LETTER OF SUSPENSION E-MAILED
11/16/2016
CNSL
SUSPENSION LETTER WRITTEN
11/16/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/10/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/10/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/10/2016
GNRT
NON-FINAL ACTION E-MAILED
05/10/2016
CNRT
NON-FINAL ACTION WRITTEN
05/10/2016
DOCK
ASSIGNED TO EXAMINER
05/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/16/2016
NWAP
NEW APPLICATION ENTERED
04/15/2016
Continuous trademark protection
Get notified about every new filing that threatens EUREKA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.